MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
Hand-out
Press Releases
MicuRx Pharmaceuticals  
November 29, 2024

MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China

SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to

avatar profile Olean Times Herald

Olean Times Herald


Local & Social